178 completed, 34 unknown, 13 recruiting, 12 not yet recruiting. 65 Phase 2, 59 Not applicable, 51 Phase 3, 31 Phase 1, 28 Phase 4.
Follow Tinea: new trials by email Literature Review of Tinea trials Research Report on Tinea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Efficacy of Luliconazole and Bifonazole Combined With Itraconazole in Dermatophytosis Itraconazole, Luliconazole Cream 1%, Bifonazole cream 1% - Tinea Corporis,Tinea Cruris,Tinea Faciei | Phase 4 | Not yet recruiting | University of Faisalabad | 182 | 2026-12-01 | 2026-11-05 |
| Safety and Efficacy Study of SKX-16 in Participants With Mild to Moderate Distal Subungual Onychomycosis SKX-16 (Luliconazole 10% Solution), Vehicle solution - Onychomycosis of Toenails | Phase 2 | Not yet recruiting | SATO Pharmaceutical Co., Ltd. | 204 | 2026-11-24 | 2026-11-10 |
| Systemic Antifungal Plus Q-Switched Nd:YAG Laser for Onychomycosis Terbinafine, Q-switched Nd:YAG laser - Onychomycosis | Not applicable | Not yet recruiting | Assiut University | 97 | 2026-10-10 | 2026-10-09 |
| In Vitro Susceptibility of Dermatophytes to Terbinafine and Itraconazole: MIC Distributions and Elevated-MIC Isolates in Faisalabad, Pakistan In vitro antifungal susceptibility testing - Dermatophytosis, Tinea Corporis | Recruiting | Dr. Amara Safdar | 120 | 2026-10-02 | 2026-10-27 | |
| Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail Itraconazole (200 mg), ISOtretinoin 20 MG - Tinea Corporis | Phase 4 | Not yet recruiting | Pak Emirates Military Hospital | 60 | 2026-10-01 | 2026-06-30 |
| Clinical, Dermoscopic, and Mycological Evaluations of Resistant Dermatophytosis Direct microscopic KOH examination, Culture:, Antifungal susceptibility testing: - Fungal Skin Infection, Tinea Corporis | Not yet recruiting | Sohag University | 100 | 2026-10-01 | 2026-09-01 | |
| Clinical, Dermoscopic, and Mycological Characteristics of Tinea Capitis in Children Dermoscopic examination: the findings are divided into pathognomic and non-specific signs, Direct Microscopy (KOH) examination, Fungal culture: - Fungal Infection by Site, Tinea Capitis | Not yet recruiting | Sohag University | 100 | 2026-09-20 | 2026-09-03 | |
| A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes ZYG24004 1% topical film-forming formulation, ZYG24004 3% topical film-forming formulation, Placebo topical formulation - Tinea Pedis | Phase 1 | Recruiting | Sinomune Pharmaceutical Co., Ltd | 64 | 2026-07-21 | 2026-08-04 |
| URGO MICKAEL Filmogel, Topical Treatment of Onychomycosis URGO MICKAEL Filmogel - Onychomycosis of Toenail | Not applicable | Recruiting | CEN Biotech | 54 | 2026-01-28 | 2026-09-22 |
| A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis Intra-Lesional MMR Immunotherapy - Tinea Corporis, Tinea Cruris | Not applicable | Recruiting | Abeer Mohamed Abdelaziz Elkholy | 50 | 2025-12-09 | 2025-12-31 |
| Oral Fluconazole vs Oral Terbinafine for Tinea Capitis in Children Aged 2-10 Years Fluconazole., Terbinafine., Ketoconazole 2% shampoo - Tinea Capitis | Phase 4 | Completed | Dr. Amara Safdar | 64 | 2025-12-01 | 2026-11-10 |
| Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis Itraconazole (200 mg), Fluconazole 150 mg - Tinea Corporis, Dermatophytosis | Phase 4 | Recruiting | Urooj Fatima | 126 | 2025-11-01 | 2026-01-15 |
| Sports Nutrition Assessment Program diet, Physical activity, body composition - Diet Habit, Body Weight | Not yet recruiting | University of Alicante | 100 | 2025-10-01 | 2025-08-05 | |
| Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis Active CAP therapy, Sham CAP therapy, standard care - Tinea Pedis | Not applicable | Recruiting | Shenyang Medical College | 220 | 2025-07-25 | 2026-01-02 |
| Effect of Kinesiotaping on Lower Limb Kinematics and Functional Related Outcomes Among Female Athletes With Chronic Lateral Ankle Instability Flexibility Exercise, Mulligan mobilization with movement, Kinesiology Taping - Kinesiotapping, Kinematics | Not applicable | Not yet recruiting | Cairo University | 50 | 2025-06-30 | 2025-07-08 |
| Trichoscopic Predictors of Treatment Response in Tinea Capitis: A Prospective Study Tinea Capitis | Completed | Istanbul Medeniyet University | 46 | 2025-06-24 | 2026-07-28 | |
| Fractional CO₂ Laser or 40% Urea With Topical Fluconazole Microemulsion in Onychomycosis "Fractional CO2 laser" and "topical fluconazole microemulsion", "Urea 40%" and "topical fluconazole microemulsion" - Onychomycosis | Not applicable | Not yet recruiting | Assiut University | 40 | 2025-06-01 | 2025-06-29 |
| Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox Onychomycosis of Toenails | Not yet recruiting | University of Bologna | 80 | 2025-05-30 | 2025-05-20 | |
| Comparative Efficacy of Topical Oxiconazole Cream (1%) Versus Topical Clotrimazole Cream (1%) in the Treatment of Tinea CrurisAbstract Topical Oxiconazole cream, Topical Clotrimazole cream - Tinea Cruris | Early Phase 1 | Completed | Hayat Abad Medical Complex, Peshawar | 386 | 2025-05-15 | 2026-02-27 |
| Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis Trichostatin A - Onychomycosis of Toenail | Phase 2 | Active not recruiting | Vanda Pharmaceuticals | 50 | 2025-05-05 | 2026-02-04 |
Showing 20 of 251. Sign in to see all of them.
Onychomycosis (136) · Tinea Pedis (70) · Tinea Capitis (16) · Tinea Cruris (15) · Mycoses (14) · Foot Dermatoses (9) · Dermatomycoses (7) · Skin Diseases (5) · Pruritus (4) · Acne Vulgaris (3) · Cellulitis (3) · Keratoderma, Palmoplantar, Epidermolytic (3) · Nails, Malformed (3) · Onycholysis (3)
Bacterial Infections and Mycoses (251) · Skin and Connective Tissue Diseases (251) · Skin Diseases, Infectious (250) · Infections (249) · Skin Diseases (246) · Dermatomycoses (244) · Mycoses (237) · Nail Diseases (134) · Pathological Conditions, Signs and Symptoms (82) · Foot Diseases (76) · Signs and Symptoms (74) · Skin Manifestations (70) · Foot Dermatoses (69) · Pruritus (68)
Terbinafine (28) · Itraconazole (15) · amorolfine (9) · naftifine (9) · tavaborole (7) · Ketoconazole (6) · Solutions (6) · 1-(2-(2,4-dichlorophenyl)-2-(4-(trifluoromethyl)benzyloxy)ethyl)-1H-imidazole (4) · Ciclopirox (4) · Fluconazole (4) · Isotretinoin (4) · Lasers (4) · butenafine (4) · efinaconazole (4) · Clotrimazole (3)
Pfizer (13) · Sun Pharmaceutical Industries, Inc. (10) · Merz North America, Inc. (9) · Stiefel, a GSK Company (5) · Erchonia Corporation (4) · Galderma R&D (4) · Mahidol University (4) · Moberg Pharma AB (4) · Nitric BioTherapeutics, Inc (4) · Sohag University (4) · AmDerma (3) · Bausch Health Americas, Inc. (3) · Cairo University (3) · DermBiont, Inc. (3) · Dow Pharmaceutical Sciences (3)
United States (105) · Canada (17) · Dominican Republic (12) · Pakistan (12) · Germany (10) · Brazil (9) · Egypt (9) · Honduras (9) · Spain (9) · France (8) · Puerto Rico (8) · Belize (7) · China (6) · Iceland (6) · Thailand (6)
Anya Loncaric (3) · Eduardo Tschen, MD (3) · Lawrence Parish, MD (3) · Ron Staugaard (3) · Alan Fleischer, MD (2) · Antonio Martorell, PhD (2) · Daniel Piacquadio, MD (2) · David Gratton, MD (2) · Gilberto De Nucci, PhD (2)
PMID 25007364, PMID 10233295, PMID 10642676, PMID 14723731, PMID 16319467, PMID 19119131, PMID 20346297, PMID 20347657, PMID 21292346, PMID 21422348, PMID 21820203, PMID 21967490, PMID 21968664, PMID 22052309, PMID 22236569, PMID 22453588, PMID 22976905, PMID 23278851, PMID 23377392, PMID 23416171, PMID 23884486, PMID 23980908, PMID 24079583, PMID 24173203, PMID 25013957, PMID 25357174, PMID 25639524, PMID 25872590, PMID 26471716, PMID 27297276, PMID 27799043, PMID 27815659, PMID 28670355, PMID 30526582, PMID 30811142, PMID 31161942, PMID 32421854, PMID 35491738, PMID 36103158, PMID 36302167, PMID 39158295, PMID 39624747, PMID 41024682, PMID 41035081, PMID 42286623
2008 (3), 2015 (2), 2009 (1)